These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 20599551)
1. Methods for DNA methylation analysis and applications in colon cancer. Jordà M; Peinado MA Mutat Res; 2010 Nov; 693(1-2):84-93. PubMed ID: 20599551 [TBL] [Abstract][Full Text] [Related]
2. DNA methylation differences associated with tumor tissues identified by genome scanning analysis. Liang G; Salem CE; Yu MC; Nguyen HD; Gonzales FA; Nguyen TT; Nichols PW; Jones PA Genomics; 1998 Nov; 53(3):260-8. PubMed ID: 9799591 [TBL] [Abstract][Full Text] [Related]
3. Molecular diagnostic applications of DNA methylation technology. Cottrell SE Clin Biochem; 2004 Jul; 37(7):595-604. PubMed ID: 15234241 [TBL] [Abstract][Full Text] [Related]
4. A sensitive new method for rapid detection of abnormal methylation patterns in global DNA and within CpG islands. Pogribny I; Yi P; James SJ Biochem Biophys Res Commun; 1999 Sep; 262(3):624-8. PubMed ID: 10471374 [TBL] [Abstract][Full Text] [Related]
5. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185 [TBL] [Abstract][Full Text] [Related]
6. De novo CpG island methylation in human cancer cells. Jair KW; Bachman KE; Suzuki H; Ting AH; Rhee I; Yen RW; Baylin SB; Schuebel KE Cancer Res; 2006 Jan; 66(2):682-92. PubMed ID: 16423997 [TBL] [Abstract][Full Text] [Related]
7. Hierarchical clustering of lung cancer cell lines using DNA methylation markers. Virmani AK; Tsou JA; Siegmund KD; Shen LY; Long TI; Laird PW; Gazdar AF; Laird-Offringa IA Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):291-7. PubMed ID: 11895880 [TBL] [Abstract][Full Text] [Related]
8. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells. Sadikovic B; Andrews J; Rodenhiser DI Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174 [TBL] [Abstract][Full Text] [Related]
9. Epigenomics of human colon cancer. Carmona FJ; Esteller M Mutat Res; 2010 Nov; 693(1-2):53-60. PubMed ID: 20691710 [TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Gonzalgo ML; Liang G; Spruck CH; Zingg JM; Rideout WM; Jones PA Cancer Res; 1997 Feb; 57(4):594-9. PubMed ID: 9044832 [TBL] [Abstract][Full Text] [Related]
11. Mass spectrometric analysis of cytosine methylation by base-specific cleavage and primer extension methods. van den Boom D; Ehrich M Methods Mol Biol; 2009; 507():207-27. PubMed ID: 18987817 [TBL] [Abstract][Full Text] [Related]
12. Experimental manipulation of genomic methylation. Jackson-Grusby L; Jaenisch R Semin Cancer Biol; 1996 Oct; 7(5):261-8. PubMed ID: 9110403 [TBL] [Abstract][Full Text] [Related]
13. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. De Marzo AM; Marchi VL; Yang ES; Veeraswamy R; Lin X; Nelson WG Cancer Res; 1999 Aug; 59(16):3855-60. PubMed ID: 10463569 [TBL] [Abstract][Full Text] [Related]
14. DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker. Tost J Methods Mol Biol; 2009; 507():3-20. PubMed ID: 18987802 [TBL] [Abstract][Full Text] [Related]
15. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer. Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637 [TBL] [Abstract][Full Text] [Related]
16. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. Esteller M; Herman JG J Pathol; 2002 Jan; 196(1):1-7. PubMed ID: 11748635 [TBL] [Abstract][Full Text] [Related]
17. [DNA methylation profiling in cancer: from single nucleotides towards methylome]. Moskalev EA; Eprintsev AT; Hoheisel JD Mol Biol (Mosk); 2007; 41(5):793-807. PubMed ID: 18240563 [TBL] [Abstract][Full Text] [Related]
18. General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells. Gebhard C; Benner C; Ehrich M; Schwarzfischer L; Schilling E; Klug M; Dietmaier W; Thiede C; Holler E; Andreesen R; Rehli M Cancer Res; 2010 Feb; 70(4):1398-407. PubMed ID: 20145141 [TBL] [Abstract][Full Text] [Related]
19. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Costello JF; Frühwald MC; Smiraglia DJ; Rush LJ; Robertson GP; Gao X; Wright FA; Feramisco JD; Peltomäki P; Lang JC; Schuller DE; Yu L; Bloomfield CD; Caligiuri MA; Yates A; Nishikawa R; Su Huang H; Petrelli NJ; Zhang X; O'Dorisio MS; Held WA; Cavenee WK; Plass C Nat Genet; 2000 Feb; 24(2):132-8. PubMed ID: 10655057 [TBL] [Abstract][Full Text] [Related]
20. Discovery of epigenetically silenced genes by methylated DNA immunoprecipitation in colon cancer cells. Jacinto FV; Ballestar E; Ropero S; Esteller M Cancer Res; 2007 Dec; 67(24):11481-6. PubMed ID: 18089774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]